Novel MRI Techniques on Evaluation of Lymphedema

NCT ID: NCT05804643

Last Updated: 2023-04-19

Basic Information

• Recruitment Status: RECRUITING
• Total Enrollment: 210 participants
• Study Classification: OBSERVATIONAL
• Study Start Date: 2023-04-10
• Study Completion Date: 2026-12-31

Brief Summary

In this project, the investigators aim to investigate the imaging approaches for breast cancer-related secondary lymphedema. The clinical study aims to optimize the conventional MRI methods for mapping lymphedema and assess the post-surgical therapeutic effects in longitudinal follow-up studies. Additionally, a normal imaging database of lymphedema MRI images will be established for future reference. For pre-clinical animal study, investigators aim to develop and integrate two novel MRI methods, including free water elimination diffusion MRI and diffusion kurtosis MRI techniques. By integrating clinical and pre-clinical studies, the investigators aim to establish a precise imaging tool for evaluating the therapeutic effects of lymphedema for following translational applications.

Detailed Description

A total of three sub-projects will be conducted in this project. Sub-project 1 will establish a pre-clinical rat model for lymphedema and develop novel MRI methods, including diffusion kurtosis MRI and free water elimination diffusion MRI techniques, for mapping tissue characteristics of lymphedema. Sub-project 1 will be complemented with the clinical images provided by sub-project 2, yielding more information about the lymphedema. Sub-project 2 aims to optimize the clinical MRI methods for mapping lymphedema and quantitatively assess the severity of lymphedema. A normal imaging database will be established for reference. Sub-project 2 and sub-project 3 will be complementary in co-developing the image assessment of post-surgical therapeutic effect. Sub-project 3 will quantitatively evaluate the severity of lymphedema secondary to different kinds of axillary treatments by using the clinical MRI methods for establishing longitudinal monitoring and prediction approaches. It also focuses on the pre-surgical and post-surgical evaluation of lymphedema undergone supermicrosurgical technique by using the clinical MRI methods.

Conditions

Lymphedema of Upper Limb

Study Design

• Observational Model Type: COHORT
• Study Time Perspective: CROSS_SECTIONAL

Study Groups

Breast cancer related lymphedema

Breast cancer related lymphedema cases receive observational magnetic resonance imaging before and after lymphovenous anastomosis.

Diffusion magnetic resonance imaging

Intervention Type: PROCEDURE

Free water elimination diffusion MRI and diffusion kurtosis MRI techniques

Interventions

Diffusion magnetic resonance imaging

Free water elimination diffusion MRI and diffusion kurtosis MRI techniques

Intervention Type: PROCEDURE

Eligibility Criteria

Inclusion Criteria

• adults with breast cancer related lymphedema

Exclusion Criteria

• children younger than 20 years old
• pregnancy
• patients who have absolute contraindications regarding MRI scanning:

1. The cardiac implantable electronic device (CIED) such as pacemakers, implantable cardioverter defibrillators (ICDs) and cardiac resynchronization therapy (CRT) devices.

2. Metallic intraocular foreign bodies.

3. Implantable neurostimulation systems

4. Cochlear implants/ear implant: bone-anchored hearing aid (BAHA) cochlear implant type can be scanned on a 1.5-tesla scanner only after the patient removes the battery. Cochlear implant wrapping scheduling must take place before the patient's MRI appointment.

5. Drug infusion pumps (insulin delivery, analgesic drugs, or chemotherapy pumps): If possible, the patient has to remove the device.

6. Catheters with metallic components (Swan-Ganz catheter)

7. Metallic fragments such as bullets, shotgun pellets, and metal shrapnel

8. Cerebral artery aneurysm clips

9. Magnetic dental implants

10. Tissue expander

11. Artificial limb

12. Hearing aid

• Minimum Eligible Age: 20 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: Yes

Sponsors

National Health Research Institutes, Taiwan

OTHER

Sponsor Role: collaborator

National Taiwan University Hospital

OTHER

Sponsor Role: lead

Responsible Party

Responsibility Role: SPONSOR

Principal Investigators

Li-Wei Kuo, Ph.D.

Role: PRINCIPAL_INVESTIGATOR

National Health Research Institutes, Taiwan

Locations

National Taiwan university hospital

Taipei, , Taiwan

Site Status: RECRUITING

Countries

Taiwan

Central Contacts

Yeefan Lee, MD

Role: CONTACT

yeefanlee@ntu.edu.tw

+886-972653172

Facility Contacts

Yeefan Lee, MD

Role: primary

yeefanlee@ntu.edu.tw

+886-2-2312-3456 ext. 262570

References

Fu MR. Breast cancer-related lymphedema: Symptoms, diagnosis, risk reduction, and management. World J Clin Oncol. 2014 Aug 10;5(3):241-7. doi: 10.5306/wjco.v5.i3.241.

Reference Type: BACKGROUND

PMID: 25114841 (View on PubMed)

Yang JC, Wu SC, Wang YM, Luo SD, Kuo SC, Chien PC, Tsai PY, Hsieh CH, Lin WC. Effect of Lymphaticovenous Anastomosis on Muscle Edema, Limb, and Subfascial Volume in Lower Limb Lymphedema: MRI Studies. J Am Coll Surg. 2022 Aug 1;235(2):227-239. doi: 10.1097/XCS.0000000000000236. Epub 2022 Apr 18.

Reference Type: BACKGROUND

PMID: 35839398 (View on PubMed)

Garza R 3rd, Skoracki R, Hock K, Povoski SP. A comprehensive overview on the surgical management of secondary lymphedema of the upper and lower extremities related to prior oncologic therapies. BMC Cancer. 2017 Jul 5;17(1):468. doi: 10.1186/s12885-017-3444-9.

Reference Type: BACKGROUND

PMID: 28679373 (View on PubMed)

Granzow JW, Soderberg JM, Kaji AH, Dauphine C. An effective system of surgical treatment of lymphedema. Ann Surg Oncol. 2014 Apr;21(4):1189-94. doi: 10.1245/s10434-014-3515-y. Epub 2014 Feb 13.

Reference Type: BACKGROUND

PMID: 24522988 (View on PubMed)

Winters H, Tielemans HJP, Hameeteman M, Paulus VAA, Beurskens CH, Slater NJ, Ulrich DJO. The efficacy of lymphaticovenular anastomosis in breast cancer-related lymphedema. Breast Cancer Res Treat. 2017 Sep;165(2):321-327. doi: 10.1007/s10549-017-4335-0. Epub 2017 Jun 12.

Reference Type: BACKGROUND

PMID: 28608029 (View on PubMed)

Executive Committee. The Diagnosis and Treatment of Peripheral Lymphedema: 2016 Consensus Document of the International Society of Lymphology. Lymphology. 2016 Dec;49(4):170-84.

Reference Type: BACKGROUND

PMID: 29908550 (View on PubMed)

Lohrmann C, Felmerer G, Foeldi E, Bartholoma JP, Langer M. MR lymphangiography for the assessment of the lymphatic system in patients undergoing microsurgical reconstructions of lymphatic vessels. Microvasc Res. 2008 May;76(1):42-5. doi: 10.1016/j.mvr.2008.03.003. Epub 2008 Mar 20.

Reference Type: BACKGROUND

PMID: 18456290 (View on PubMed)

Notohamiprodjo M, Weiss M, Baumeister RG, Sommer WH, Helck A, Crispin A, Reiser MF, Herrmann KA. MR lymphangiography at 3.0 T: correlation with lymphoscintigraphy. Radiology. 2012 Jul;264(1):78-87. doi: 10.1148/radiol.12110229. Epub 2012 Apr 20.

Reference Type: BACKGROUND

PMID: 22523325 (View on PubMed)

Franconeri A, Ballati F, Panzuto F, Raciti MV, Smedile A, Maggi A, Asteggiano C, Esposito M, Stoppa D, Lungarotti L, Bortolotto C, Giardini D, De Silvestri A, Calliada F. A proposal for a semiquantitative scoring system for lymphedema using Non-contrast Magnetic Resonance Lymphography (NMRL): Reproducibility among readers and correlation with clinical grading. Magn Reson Imaging. 2020 May;68:158-166. doi: 10.1016/j.mri.2020.02.004. Epub 2020 Feb 10.

Reference Type: BACKGROUND

PMID: 32057940 (View on PubMed)

Crescenzi R, Donahue PMC, Hartley KG, Desai AA, Scott AO, Braxton V, Mahany H, Lants SK, Donahue MJ. Lymphedema evaluation using noninvasive 3T MR lymphangiography. J Magn Reson Imaging. 2017 Nov;46(5):1349-1360. doi: 10.1002/jmri.25670. Epub 2017 Feb 28.

Reference Type: BACKGROUND

PMID: 28245075 (View on PubMed)

Arrive L, Derhy S, El Mouhadi S, Monnier-Cholley L, Menu Y, Becker C. Noncontrast Magnetic Resonance Lymphography. J Reconstr Microsurg. 2016 Jan;32(1):80-6. doi: 10.1055/s-0035-1549133. Epub 2015 Mar 31.

Reference Type: BACKGROUND

PMID: 25826439 (View on PubMed)

Lohrmann C, Foeldi E, Speck O, Langer M. High-resolution MR lymphangiography in patients with primary and secondary lymphedema. AJR Am J Roentgenol. 2006 Aug;187(2):556-61. doi: 10.2214/AJR.05.1750.

Reference Type: BACKGROUND

PMID: 16861563 (View on PubMed)

Bae JS, Yoo RE, Choi SH, Park SO, Chang H, Suh M, Cheon GJ. Evaluation of lymphedema in upper extremities by MR lymphangiography: Comparison with lymphoscintigraphy. Magn Reson Imaging. 2018 Jun;49:63-70. doi: 10.1016/j.mri.2017.12.024. Epub 2018 Jan 3.

Reference Type: BACKGROUND

PMID: 29306049 (View on PubMed)

Hagmann P, Jonasson L, Maeder P, Thiran JP, Wedeen VJ, Meuli R. Understanding diffusion MR imaging techniques: from scalar diffusion-weighted imaging to diffusion tensor imaging and beyond. Radiographics. 2006 Oct;26 Suppl 1:S205-23. doi: 10.1148/rg.26si065510.

Reference Type: BACKGROUND

PMID: 17050517 (View on PubMed)

Basser PJ, Mattiello J, LeBihan D. MR diffusion tensor spectroscopy and imaging. Biophys J. 1994 Jan;66(1):259-67. doi: 10.1016/S0006-3495(94)80775-1.

Reference Type: BACKGROUND

PMID: 8130344 (View on PubMed)

Jensen JH, Helpern JA, Ramani A, Lu H, Kaczynski K. Diffusional kurtosis imaging: the quantification of non-gaussian water diffusion by means of magnetic resonance imaging. Magn Reson Med. 2005 Jun;53(6):1432-40. doi: 10.1002/mrm.20508.

Reference Type: BACKGROUND

PMID: 15906300 (View on PubMed)

Jensen JH, Helpern JA. MRI quantification of non-Gaussian water diffusion by kurtosis analysis. NMR Biomed. 2010 Aug;23(7):698-710. doi: 10.1002/nbm.1518.

Reference Type: BACKGROUND

PMID: 20632416 (View on PubMed)

Chhetri A, Li X, Rispoli JV. Current and Emerging Magnetic Resonance-Based Techniques for Breast Cancer. Front Med (Lausanne). 2020 May 12;7:175. doi: 10.3389/fmed.2020.00175. eCollection 2020.

Reference Type: BACKGROUND

PMID: 32478083 (View on PubMed)

Tang L, Zhou XJ. Diffusion MRI of cancer: From low to high b-values. J Magn Reson Imaging. 2019 Jan;49(1):23-40. doi: 10.1002/jmri.26293. Epub 2018 Oct 12.

Reference Type: BACKGROUND

PMID: 30311988 (View on PubMed)

Li Z, Li X, Peng C, Dai W, Huang H, Li X, Xie C, Liang J. The Diagnostic Performance of Diffusion Kurtosis Imaging in the Characterization of Breast Tumors: A Meta-Analysis. Front Oncol. 2020 Oct 27;10:575272. doi: 10.3389/fonc.2020.575272. eCollection 2020.

Reference Type: BACKGROUND

PMID: 33194685 (View on PubMed)

Liu W, Wei C, Bai J, Gao X, Zhou L. Histogram analysis of diffusion kurtosis imaging in the differentiation of malignant from benign breast lesions. Eur J Radiol. 2019 Aug;117:156-163. doi: 10.1016/j.ejrad.2019.06.008. Epub 2019 Jun 17.

Reference Type: BACKGROUND

PMID: 31307642 (View on PubMed)

Rosenkrantz AB, Padhani AR, Chenevert TL, Koh DM, De Keyzer F, Taouli B, Le Bihan D. Body diffusion kurtosis imaging: Basic principles, applications, and considerations for clinical practice. J Magn Reson Imaging. 2015 Nov;42(5):1190-202. doi: 10.1002/jmri.24985. Epub 2015 Jun 26.

Reference Type: BACKGROUND

PMID: 26119267 (View on PubMed)

Collier Q, Veraart J, Jeurissen B, Vanhevel F, Pullens P, Parizel PM, den Dekker AJ, Sijbers J. Diffusion kurtosis imaging with free water elimination: A bayesian estimation approach. Magn Reson Med. 2018 Aug;80(2):802-813. doi: 10.1002/mrm.27075. Epub 2018 Feb 2.

Reference Type: BACKGROUND

PMID: 29393531 (View on PubMed)

Bergamino M, Walsh RR, Stokes AM. Free-water diffusion tensor imaging improves the accuracy and sensitivity of white matter analysis in Alzheimer's disease. Sci Rep. 2021 Mar 26;11(1):6990. doi: 10.1038/s41598-021-86505-7.

Reference Type: BACKGROUND

PMID: 33772083 (View on PubMed)

Other Identifiers

202301160RINA

Identifier Type: -

Identifier Source: org_study_id